Alzheimer’s
-
Stories
A cure for Alzheimer’s has arrived in 2022 as the newly discovered drug hailed a historic moment
Japanese Drugmaker Eisai stated that cognitive decline in Alzheimer’s patients slowed in patients within 18 months who were administered the…
Read More » -
Stories
The quixotic search for an Alzheimer’s “Magic bullet” is prolonged by yet another failure.
Clinical studies for an experimental Alzheimer’s medicine designed to halt or prevent cognitive loss in patients at high risk of…
Read More » -
Stories
FDA approves conditional trial for Alzheimer’s drug: A Silver Lining.
In a huge breakthrough, America’s Food and Drug Administration (FDA) has sanctioned conditional approval to a brand new drug, aducanumab,…
Read More » -
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases
For the past nineteen years, Ioannis Tarnanas, the founder and chief scientific officer at Altoida, has been developing virtual and…
Read More »